Promo Companies: AI Sales Tools Redefine 2026
AI sales tools are now a reality for promo companies. See how AI predicts churn, boosts sales by 15%, and saves reps 5 hours weekly.
AI sales tools are now a reality for promo companies. See how AI predicts churn, boosts sales by 15%, and saves reps 5 hours weekly.
Is the 340B drug discount program working? See why 2026 policy changes aim to boost transparency and ensure benefits reach vulnerable patients.
Operating in the Middle East? See 5 strategies for 2026 success, from geopolitical risk to supply chain resilience and local partnerships.
Did Trump's MFN drug deals fail to lower US prescription costs? Public Citizen weighed in. See why the policy stalled and what's next.
HANK AI automates promo product inquiries and personalizes recommendations, cutting operational costs. See how it works.
US-Canada dairy disputes cost hundreds of millions in lost exports. Learn why Canada's system creates tension and what's next for USMCA.
Iambic's IPO shows AI's impact on pharma investing. Learn why investors bet on AI to shorten drug development cycles by 2026.
Carbon markets reached $1.2 trillion in 2025. What's driving this growth, how will EU ETS and China's expansion impact policy, and what are the challenges a
AI tools will cut diagnosis time by 30% for complex conditions by 2026. Learn how AI boosts accuracy, reduces errors, and impacts healthcare.
Are 2026 battery fire safety protocols enough? Learn why current rules are inadequate given rapid tech changes and 1 lithium-ion risks.